Turkmenistan Health News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Turkmenistan Health News.

Press releases published on June 5, 2026

Jun. 5, 2026

Cosmos Health Continues U.S. Expansion with Launch of Oliv18, Targeting Cardiovascular and Antioxidant Categories

Indeterminate GlobeNewswire

Jun. 5, 2026

Edesa Biotech Reports Positive Exploratory Data for Paridiprubart in Patients with Acute Kidney Injury

Indeterminate GlobeNewswire

Jun. 5, 2026

ENvue Medical Expands into Burn Intensive Care Unit at Major Academic Health Network

Indeterminate GlobeNewswire

Jun. 5, 2026

WORK Medical Technology Group Participated in 2026 CBA-China Annual Conference

Indeterminate GlobeNewswire

Jun. 5, 2026

Global Norovirus Outbreaks, Ebola Emergency and Rising Disease Threats Highlight Growing Need for TOMI Environmental Solutions' SteraMist Technology

Indeterminate GlobeNewswire

Jun. 5, 2026

NRx Pharmaceuticals (Nasdaq:NRXP) notes presentation by Osmind, Inc. of IV Ketamine Efficacy vs. Nasal esketamine Efficacy at American Society of Clinical Psychopharmacology.

Indeterminate GlobeNewswire

Jun. 5, 2026

Vivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Support Continued Nasdaq Listing

Indeterminate GlobeNewswire

Jun. 5, 2026

Vivos Inc. (OTCQB: RDGL) submits Early Feasibility Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) for RadioGel® Precision Radionuclide Therapy™

Indeterminate GlobeNewswire

Jun. 5, 2026

Independent Market Research Finds Strong Physician Intent to Prescribe Moleculin's Annamycin in Relapsed/Refractory AML

Indeterminate GlobeNewswire

Jun. 5, 2026

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 5, 2026

Collegium Pharmaceutical Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 5, 2026

Eos SENOLYTIX Presents Best-in-Class Preclinical Body Composition Data Highlighting Unique Muscle Mass Gains with MitoXcel™ Geropeptide PTC-2105 at the Sachs 2nd Annual Obesity & Cardiometabolic Innovation Forum

Indeterminate GlobeNewswire

Jun. 5, 2026

Amneal Announces Full Study Population Interim Phase 4 ELEVATE-PD Results, Reinforcing Previously Reported Benefits of CREXONT® in Parkinson's Disease

Indeterminate GlobeNewswire

Jun. 5, 2026

UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 5, 2026

FDA Confirms CardiAMP HF II May Support Premarket Approval of CardiAMP Cell Therapy for Ischemic HFrEF

Indeterminate GlobeNewswire

Jun. 5, 2026

MISOORA Unveils Revolutionary K-Beauty Skincare Range Emphasizing Longevity Over Anti-Aging

Indeterminate GlobeNewswire

Jun. 5, 2026

Clearmind Medicine to Feature New Insights from CMND-100 Psychedelic Clinical Trial on “Inside MEAI” Webinar

Indeterminate GlobeNewswire

Jun. 5, 2026

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 5, 2026

Foghorn Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026

Indeterminate GlobeNewswire

Jun. 5, 2026

Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire